Skip to main content

What benefits of the Wegovy Pill have been shown in studies?

In the OASIS 4 phase 3 trial (a randomised, double-blind, placebo-controlled study over 64 weeks), participants taking the 25mg dose alongside diet and exercise support lost an average of 16.6% of body weight, versus 2.2% on placebo.

Appetite changes typically show up in weeks 1–8, measurable weight loss from week 8, and the strongest results from week 16+ once patients reach the maintenance dose. Figures assume full adherence in a trial population; individual results vary.

Did this answer your question?